Influenza therapeutics encompass treatments aimed at managing and alleviating flu symptoms. This includes antiviral medications that inhibit the virus's replication, symptomatic treatments to relieve fever and aches, and vaccines to prevent infection. Supportive care, such as rest and hydration, also plays a role in aiding recovery. The primary goal is to reduce symptom severity, shorten illness duration, and prevent complications.

Influenza Therapeutics Market Overview

Global Influenza Therapeutics Market is expected to reach at a high CAGR during the forecast period 2024-2031.

Influenza is a contagious respiratory illness caused by the influenza virus, characterized by symptoms such as chills, fever, and body aches. It is commonly spread when people inhale tiny airborne droplets released by the coughs or sneezes of infected individuals. To reduce the risk of severe complications, including death, the Centers for Disease Control and Prevention (CDC) recommends that people receive a flu vaccine each year.

Influenza outbreaks occur annually, and many people with flu-like symptoms rely on over-the-counter medications, including antiviral and antimicrobial drugs, for relief. According to the World Health Organization (WHO), the global annual attack rate of influenza affects approximately 20% to 30% of children and around 10% of adults. Influenza-related deaths worldwide are estimated to range from 290,000 to 650,000 each year.

Request for free sample:https://www.datamintelligence.com/download-sample/influenza-therapeutics-market

Influenza Therapeutics Market Dynamics

There is an increasing focus on clinical trials for vaccines, aimed at evaluating their safety, immunogenicity, and efficacy. These trials are crucial for developing vaccines that are more effective and have fewer adverse effects. For example, Mahidol University and the Government Pharmaceutical Organization are conducting phase 3 clinical trials to assess the immunogenicity and safety of Tri Fluvac, a seasonal trivalent inactivated split virion influenza vaccine. According to clinicaltrials.gov, the trial began on August 3, 2020, and is expected to be completed by December 31, 2023.

Get your customized report @https://www.datamintelligence.com/customize/influenza-therapeutics-market

Influenza Therapeutics Market is segmented 

By Disease Type:  Influenza Type A, Influenza Type B, Influenza Type C, Influenza Type D

By Therapeutics:  Medication, Vaccines, Others

By Route of Administration:  Oral, Inhaled, Injectables

By End User:  Hospitals and Clinics, Specialty Centers, Others

By Region:  North America, Latin America, Europe, Asia Pacific, Middle East, and Africa

Influenza Therapeutics Market Companies

·         Merck KGaA

·         Santa Cruz Biotechnology, Inc.

·         Biosynth

·         Teva Pharmaceuticals USA, Inc.

·         Biorbyt Ltd.

·         Thermo Fisher Scientific Inc.

·         Steris

·         Healthcare PVT Ltd.

·         Genentech, Inc.

·         Lupin Pharmaceuticals, Inc.

·         BioCryst Pharmaceuticals

Related Reports

Listeriosis Market

Fucosidosis Treatment Market

Chronic Inflammation Treatment Market

Contact Us:

Company Name: DataM Intelligence

Email: info@datamintelligence.com

Contact Person: Sai. K

Phone: +1 877 441 4866

Website: https://www.datamintelligence.com

About DataM Intelligence:

DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. At DataM Intelligence, we leverage our top trademark trends, insights, and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across